How Does Latisse Work
The Science Behind Latisse
Latisse contains bimatoprost ophthalmic solution at a 0.03% concentration. Bimatoprost is a synthetic prostaglandin analog, a compound that mimics a natural substance your body uses to regulate various cell processes. The FDA approved Latisse in December 2008 as the only prescription treatment for eyelash hypotrichosis (inadequate or sparse eyelashes).
Bimatoprost was first developed as a glaucoma medication that lowers eye pressure. Doctors noticed that patients using it for glaucoma grew longer, thicker, darker eyelashes as a side effect. This observation led to the development of Latisse at the same concentration, applied to the eyelid skin rather than inside the eye as a drop.
Your eyelashes go through a growth cycle with three phases: anagen (active growth), catagen (transition), and telogen (resting and shedding). Bimatoprost extends the anagen phase so each lash grows for a longer period before it stops and enters the transition phase. The medication also increases the percentage of your lash follicles that are in the active growth phase at any given time.
This combination makes your lashes appear longer, fuller, and darker because more of them are growing at once and each individual lash grows longer before it sheds. The exact molecular mechanism by which bimatoprost achieves these changes is not fully understood. Researchers believe it acts on prostaglandin receptors in the hair follicle, but the precise signaling pathway continues to be studied.
Phase 3 clinical trials demonstrated measurable improvements in eyelash length, thickness, and darkness compared to a placebo at weeks 8, 12, and 16 of nightly use. The FDA Summary Review confirmed a 25% increase in length, 106% increase in thickness, and 18% increase in darkness at 4 months compared to placebo (FDA NDA 022369).
In pediatric patients, 70.8% showed improved eyelash prominence with bimatoprost versus 26.1% with placebo at month 4 (PMC, 2010; PMC, 2016). These results were consistent across multiple study populations, confirming that bimatoprost produces real, measurable lash growth.
How to Use Latisse
You apply Latisse once each night to the base of your upper eyelid lashes using the sterile applicator that comes with the prescription. Place a single drop of solution on the applicator tip and draw it across the skin along your upper lash line from the inner to the outer corner of your eye. Use one applicator per eye and dispose of it after a single use to prevent contamination.
- Apply to your upper eyelid lash line only, not the lower lid
- Use one sterile applicator per eye per application
- Remove contact lenses before applying and wait at least 15 minutes before reinserting
- Blot any excess solution that runs beyond the lash line with a tissue
Most patients begin to notice changes at 4 to 8 weeks of consistent nightly use. Your lashes become gradually longer and darker during this period. Full results appear at 16 weeks, when the maximum number of lashes have completed an extended growth cycle. You need to continue using Latisse to maintain the results because new lashes that grow in without the medication will return to your natural baseline length and thickness.
If you stop applying the solution, your lashes return to their pre-treatment appearance over several weeks to months as the treated lashes naturally shed and are replaced by untreated growth.
Your eye doctor should evaluate you before prescribing Latisse if you have active eye inflammation such as uveitis (inflammation inside the eye), a history of elevated eye pressure, or if you currently use another prostaglandin analog eye drop for glaucoma management. Latisse requires a prescription, so your doctor will review your eye health, check your eye pressure, and confirm the medication is appropriate for your situation.
Patients who are pregnant or breastfeeding should discuss the risks with their doctor before starting Latisse, as safety data in these populations is limited.
Side Effects and Safety
The most common side effect is conjunctival hyperemia (redness of the white part of your eye), occurring in 5% or more of users in clinical trials. Some patients experience skin darkening at the application site, eyelid pigmentation changes, eye itching, or a dry eye sensation. These effects are related to the prostaglandin mechanism of the medication and may decrease with continued use or resolve when you stop applying Latisse.
Bimatoprost can darken the color of your iris (the colored part of your eye) if the solution contacts your iris directly. According to the AAO, this color change may be irreversible in patients with mixed-color irises, such as green-brown or blue-brown eyes. The risk is higher if the solution drips into your eye rather than staying on the eyelid skin. Careful application technique and blotting excess solution with a tissue help reduce this risk.
Patients with solid dark brown irises are less likely to notice a color change, but the risk still exists. Discuss your specific risk with your eye doctor based on your iris color.
Because bimatoprost is the same active ingredient used in glaucoma eye drops to lower intraocular pressure (IOP), applying Latisse near your eye can have a mild pressure-lowering effect. For most people this is not a concern. However, if you have glaucoma, are at risk for elevated eye pressure, or take other eye pressure medications, discuss this with your eye doctor before starting Latisse. Your doctor may want to check your eye pressure before and during treatment.
Common Questions About How Latisse Works
Latisse contains bimatoprost, a medication that can affect your eye pressure, iris color, and eyelid skin pigmentation. A prescription requirement allows your eye doctor to evaluate whether the medication is safe for your individual eye health and to monitor for side effects during use.
Latisse is approved for application on the upper eyelid lash line only. The manufacturer instructs patients not to apply it directly to the lower lid because doing so increases the amount of medication that enters your eye. Some solution from the upper lid may reach your lower lashes naturally as it spreads, but direct lower lid application is not recommended.
Missing a single application will not undo your progress. Apply Latisse the next evening as usual and do not double the dose to make up for a missed night. Consistent nightly use gives the best results, but an occasional missed application does not reset your growth cycle to the beginning.
Over-the-counter lash serums do not contain bimatoprost and are not FDA-approved to grow eyelashes. Some contain prostaglandin analogs at lower or different concentrations with limited clinical evidence behind them. Latisse is the only product with FDA approval based on controlled clinical trial data showing measurable increases in lash length, thickness, and darkness.
Your lashes reach their maximum improvement at about 16 weeks of consistent use. Continued application maintains the result but does not produce additional growth beyond that point. Your eyelash growth cycle has a natural length limit that bimatoprost extends but cannot override indefinitely.
Bimatoprost can increase melanin production in the iris if the solution enters the eye. Patients with mixed-color irises (blue-brown, green-brown, yellow-brown) face the highest risk of noticeable darkening. According to the AAO, this change may not reverse after you stop the medication. Patients with solid brown or solid blue irises have a lower risk of visible change, but careful application remains important.
Talk to Your Eye Doctor About Latisse
Your eye doctor can determine whether Latisse is right for your lash goals and eye health. A prescription evaluation includes checking your eye pressure, examining your eyelid health, and reviewing medications that might interact with bimatoprost.